Verition Fund Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $13,456 - $16,718	-1,080 Reduced 5.92%	17,160 $218,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $242,227 - $291,110	18,240 New	18,240 $256,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $411,664 - $849,525	-12,241 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $99,316 - $219,090	-3,133 Reduced 20.38%	12,241 $762,000
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $306,711 - $597,279	15,374 New	15,374 $522,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.